Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
For Orange County patients, location matters
Chen Q, Wang J, Xiong X, Chen J, Wang B, Yang H et al (2025) Bloodbrain barrierpenetrating metalorganic framework antioxidant nanozymes for targeted ischemic stroke therapy
Label the vial with the reconstitution date and refrigerate at 28 C (35.646.4 F) , protected from light
Pregnancy Tell your healthcare provider if you are pregnant or plan to become pregnant Tell your healthcare provider if you become pregnant while using MOUNJARO Limited data on MOUNJARO use in pregnant women are available to inform on drug-associated risk for major birth defects, miscarriage, or other adverse maternal or fetal outcomes Based on animal reproduction studies, there may be risks to the fetus from exposure to MOUNJARO Use only if potential benefit justifies the potential risk to the fetus Lactation It is not known if MOUNJARO passes into your breast milk Talk to your healthcare provider about the best way to feed your baby while using MOUNJARO There are no data on the presence of MOUNJARO in human milk, the effects on the breastfed infant, or the effects on milk production
The pattern is consistent every time
